Paper
16 February 2010 Transferrin protein nanospheres: a nanoplatform for receptor-mediated cancer cell labeling and gene delivery
Michael A. McDonald, Tighe A. Spurlin, Alessandro Tona, John T. Elliott, Michael Halter, Anne L. Plant
Author Affiliations +
Abstract
This paper presents preliminary results on the use of transferrin protein nanospheres (TfpNS) for targeting cancer cells in vitro. Protein nanospheres represent an easily prepared and modifiable nanoplatform for receptor-specific targeting, molecular imaging and gene delivery. Rhodamine B isothiocyanate conjugated TfpNS (RBITC-TfpNS) show significantly enhanced uptake in vitro in SK-MEL-28 human malignant melanoma cells known to overexpress transferrin receptors compared to controls. RBITCTfpNS labeling of the cancer cells is due to transferrin receptor-mediated uptake, as demonstrated by competitive inhibition with native transferrin. Initial fluorescence microscopy studies indicate GFP plasmid can be transfected into melanoma cells via GFP plasmid encapsulated by TfpNS.
© (2010) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Michael A. McDonald, Tighe A. Spurlin, Alessandro Tona, John T. Elliott, Michael Halter, and Anne L. Plant "Transferrin protein nanospheres: a nanoplatform for receptor-mediated cancer cell labeling and gene delivery", Proc. SPIE 7576, Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications II, 75760J (16 February 2010); https://doi.org/10.1117/12.842757
Lens.org Logo
CITATIONS
Cited by 1 scholarly publication.
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Proteins

Cancer

Particles

Control systems

Green fluorescent protein

Receptors

In vitro testing

Back to Top